<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">IPRATROPIUM BROMIDE <img border="0" src="../images/pr.gif"/></span><br/>(i-pra-troe'pee-um)<br/><span class="topboxtradename">Atrovent, Atrovent HFA<br/></span><b>Classifications:</b> <span class="classification">autonomic nervous system agent</span>; <span class="classification">anticholinergic (parasympatholytic)</span>; <span class="classification">antimuscarinic</span>; <span class="classification">bronchodilator</span><br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>0.02% solution for inhalation; 18 mcg inhaler; 0.03%, 0.06% nasal spray</p>
<h1><a name="action">Actions</a></h1>
<p>Quaternary compound, chemically related to atropine, with low solubility; does not cross bloodbrain barrier. Produces
         local, site-specific effects on the larger central airways including bronchodilation and prevention of bronchospasms.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Bronchodilation inhibits acetylcholine at its receptor sites, thereby blocking cholinergic bronchomotor tone (bronchoconstriction);
         also abolishes vagally mediated reflex bronchospasm triggered by such nonspecific agents as cigarette smoke, inert dusts,
         cold air, and a range of inflammatory mediators (e.g., histamine).
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Maintenance therapy in COPD including chronic bronchitis and emphysema; nasal spray for perennial rhinitis and symptomatic
         relief of rhinorrhea associated with the common cold.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Perennial nonallergic rhinitis.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Use as primary treatment for acute episodes; hypersensitivity to atropine or derivatives. Safe use in children <img src="../images/special/lesserorequal.gif"/>3
         y is not established.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Pregnancy (category B), lactation; narrow-angle glaucoma; prostatic hypertrophy, bladder neck obstruction.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">COPD</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Inhalation</span> 2 inhalations of MDI q.i.d. at no less than 4 h intervals (max: 12 inhalations in 24 h) <span class="rdroute">Nebulizer</span> 500 mcg (1 unit dose vial) q68h<br/><span class="rdage">Child:</span> <span class="rdroute">Inhalation</span>
<i>3</i><i>12 y</i>, 12 inhalations t.i.d. (max: 6/d) <span class="rdroute">Nebulizer</span> 125250 mcg t.i.d.<br/><br/><span class="indicationtitle">Rhinitis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Intranasal</span> <img src="../images/special/greaterorequal.gif"/><i>5 y</i>, 2 sprays of 0.03% each nostril b.i.d. or t.i.d.<br/><br/><span class="indicationtitle">Common Cold</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Intranasal</span> 2 sprays of 0.06% each nostril t.i.d. or q.i.d. up to 4 d<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Intranasal/</span><span class="adminroutetype">Inhalation/</span><span class="adminroutetype">Nebulizer</span><br/><ul>
<li>Demonstrate aerosol use and check return demonstration.</li>
<li>Wait 3 min between inhalations if more than one inhalation per dose is ordered.</li>
<li>Avoid contact with eyes.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Special Senses:</span> Blurred vision (especially if sprayed into eye), difficulty in accommodation, acute eye pain, worsening of narrow-angle glaucoma. <span class="typehead">GI:</span> Bitter taste, dry oropharyngeal membranes. With higher doses: nausea, constipation. <span class="typehead">Respiratory:</span>
<span class="speceff-common">Cough,</span> hoarseness, exacerbation of symptoms, drying of bronchial secretions, mucosal ulcers, epistaxis, nasal dryness. <span class="typehead">Skin:</span> Rash, hives. <span class="typehead">Urogenital:</span> Urinary retention. <span class="typehead">CNS:</span> Headache. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> 10% of inhaled dose reaches lower airway; approximately 0.5% of dose is systemically absorbed. <span class="typehead">Peak:</span> 1.52 h. <span class="typehead"> Duration:</span> 46 h. <span class="typehead">Elimination:</span> 48% of dose excreted in feces; Half-Life: 1.52 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor respiratory status; auscultate lungs before and after inhalation.</li>
<li>Report treatment failure (exacerbation of respiratory symptoms) to physician.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>
            							Note: This medication is not an emergency agent because of its delayed onset and the time required to reach peak bronchodilation.
            						
         </li>
<li>Review patient information sheet on proper use of nasal spray.</li>
<li>Allow 3060 sec between puffs for optimum results. Do not let medication contact your eyes.</li>
<li>Wait 5 min between this and other inhaled medications. Check with physician about sequence of administration.</li>
<li>Take medication only as directed, noting some leniency in number of puffs within 24 h. Supervise child's administration until
            certain all of dose is being administered.
         </li>
<li>Rinse mouth after medication puffs to reduce bitter taste.</li>
<li>Discuss changes in normal urinary pattern with the physician (more common in older adults).</li>
<li>Call physician if you note changes in sputum color or amount, ankle edema, or significant weight gain.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>